ARA named radiopharmaceutical 'center of excellence'

2020 02 03 22 07 3929 Trophy Award 400

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has certified ARA Diagnostic Imaging's ARA Theranostics Center as a radiopharmaceutical therapy center of excellence.

The theranostics center, which opened in 2021, offers prostate specific membrane antigen-based therapy for prostate cancer and peptide receptor radionuclide therapy.

Page 1 of 436
Next Page